ストックスクリーナーアプリを入手
11.80
3.24%
0.37
前日終値:
$11.43
開ける：
$11.68
24時間の取引高:
360.50K
Relative Volume:
5.55
時価総額：
$192.79M
収益：
-
当期純損益:
$-33.82M
株価収益率:
-0.4611
EPS:
-25.5891
ネットキャッシュフロー:
$-66.04M
1週間 パフォーマンス:
+19.92%
1か月 パフォーマンス:
+26.61%
6か月 パフォーマンス:
+38.17%
1年 パフォーマンス:
+164.57%
1日の値動き範囲:
$11.39
$11.97
1週間の範囲:
$11.00
$12.42
52週間の値動き範囲:
$3.70
$12.42
Elicio Therapeutics Inc Stock (ELTX) Company Profile
名前
Elicio Therapeutics Inc
セクター
電話
(857) 209-0050
住所
451 D STREET, 5TH FLOOR, BOSTON
ELTX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ELTX
Elicio Therapeutics Inc
|
11.80 | 192.46M | 0 | -33.82M | -66.04M | -25.59 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Elicio Therapeutics Inc (ELTX) 最新ニュース
Is a relief rally coming for Elicio Therapeutics Inc. holdersJuly 2025 Sentiment & Stock Portfolio Risk Management - Newser
What to expect from Elicio Therapeutics Inc. in the next 30 daysWeekly Loss Report & AI Based Buy/Sell Signal Reports - Newser
Tick level data insight on Elicio Therapeutics Inc. volatilityPortfolio Profit Report & Reliable Price Breakout Alerts - Newser
Why Elicio Therapeutics Inc. is moving todayVolume Spike & Proven Capital Preservation Methods - Newser
Can machine learning forecast Elicio Therapeutics Inc. recovery2025 Performance Recap & Consistent Income Trade Ideas - Newser
Signal strength of Elicio Therapeutics Inc. stock in tech scanners2025 Momentum Check & Free Community Supported Trade Ideas - Newser
Forecasting Elicio Therapeutics Inc. price range with options dataEarnings Overview Summary & Free High Return Stock Watch Alerts - Newser
Building trade automation scripts for Elicio Therapeutics Inc.July 2025 PreEarnings & Long Hold Capital Preservation Plans - Newser
Using Bollinger Bands to evaluate Elicio Therapeutics Inc.July 2025 PreEarnings & Long Hold Capital Preservation Plans - Newser
Analyzing Elicio Therapeutics Inc. with risk reward ratio chartsTrade Risk Assessment & Daily Volume Surge Trade Alerts - Newser
Can technical indicators confirm Elicio Therapeutics Inc.’s reversalMarket Growth Review & Low Risk High Reward Ideas - Newser
News impact scoring models applied to Elicio Therapeutics Inc.2025 Retail Activity & Stepwise Trade Signal Implementation - Newser
Key External Factors That Drive Elicio Therapeutics Inc. Stock Price MovementsEarnings Recap Report & Advanced Swing Trade Entry Alerts - Newser
What recovery options are there for Elicio Therapeutics Inc.July 2025 Big Picture & Safe Entry Momentum Stock Tips - Newser
Is it too late to sell Elicio Therapeutics Inc.Earnings Growth Summary & Reliable Price Breakout Signals - Newser
Elicio Therapeutics Soars 21.92% to 52-Week High Amid Biotech Sector Surge – What’s Fueling This Rally? - AInvest
Elicio To Report Key Phase II Data On Cancer Immunotherapy Vaccine In Q4; Stock Hits New High - RTTNews
Elicio Therapeutics Soars 19.15% Intraday: Biotech Breakthroughs and Gamma-Driven Options Ignite Speculative Frenzy - AInvest
Elicio Therapeutics Soars 17.7%: What's Fueling This Biotech Surge? - AInvest
Can trapped investors hope for a rebound in Elicio Therapeutics Inc.2025 Geopolitical Influence & High Accuracy Investment Signals - Newser
What does recent volatility data suggest for Elicio Therapeutics Inc.2025 Geopolitical Influence & High Accuracy Investment Signals - Newser
Risk vs reward if holding onto Elicio Therapeutics Inc.2025 Trade Ideas & Consistent Growth Equity Picks - Newser
Evaluating Elicio Therapeutics Inc. with trendline analysis2025 Market Outlook & Risk Managed Investment Signals - Newser
Is Elicio Therapeutics Inc. impacted by rising rates2025 Performance Recap & Community Verified Swing Trade Signals - thegnnews.com
How hedge fund analytics apply to Elicio Therapeutics Inc. stockMarket Performance Recap & Weekly Return Optimization Alerts - Newser
Analyzing recovery setups for Elicio Therapeutics Inc. investorsBreakout Watch & Safe Swing Trade Setups - Newser
Visual trend scoring systems applied to Elicio Therapeutics Inc.Weekly Trend Recap & AI Driven Price Predictions - Newser
What makes Elicio Therapeutics Inc. stock price move sharplyJuly 2025 Momentum & Daily Stock Momentum Reports - thegnnews.com
Market reaction to Elicio Therapeutics Inc.’s recent news2025 Momentum Check & Weekly Sector Rotation Insights - Newser
Is Elicio Therapeutics Inc. Stock Overbought or Oversold RSI Indicator Analysis2025 Price Action Summary & Step-by-Step Swing Trade Plans - Newser
Applying chart zones and confluence areas to Elicio Therapeutics Inc.July 2025 Volume & Risk Managed Investment Signals - Newser
Elicio Therapeutics Inc (ELTX) 財務データ
収益
当期純利益
現金流量
EPS
0.94%
1.72%
大文字化:
|
ボリューム (24 時間):